These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25123453)

  • 1. High expression of microRNA-130b correlates with poor prognosis of patients with hepatocellular carcinoma.
    Wang WY; Zhang HF; Wang L; Ma YP; Gao F; Zhang SJ; Wang LC
    Diagn Pathol; 2014 Aug; 9():160. PubMed ID: 25123453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of microRNA-106b is associated with poor prognosis in hepatocellular carcinoma.
    Li BK; Huang PZ; Qiu JL; Liao YD; Hong J; Yuan YF
    Diagn Pathol; 2014 Dec; 9():226. PubMed ID: 25466449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of microRNA-25 associates with prognosis in hepatocellular carcinoma.
    Su ZX; Zhao J; Rong ZH; Geng WM; Wu YG; Qin CK
    Diagn Pathol; 2014 Mar; 9():47. PubMed ID: 24593846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of miR-21 predicts poor prognosis in patients with hepatocellular carcinoma.
    Huang CS; Yu W; Cui H; Wang YJ; Zhang L; Han F; Huang T
    Int J Clin Exp Pathol; 2015; 8(6):7234-8. PubMed ID: 26261620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Prognostic Significance of miR-21 Expression among Surgically Resected Hepatocellular Carcinoma Patients: Evidence from a Meta-Analysis and Retrospective Cohort Study.
    Huang X; Xiong Y; Yang J; Yang G; Li J
    Biomed Res Int; 2020; 2020():8848158. PubMed ID: 33415165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM; Xu JF; Fang F; Yang H; Yang LY
    Tumour Biol; 2016 Aug; 37(8):10609-19. PubMed ID: 26861561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic values of microRNA-130 family expression in patients with cancer: a meta-analysis and database test.
    Peng Z; Duan F; Yin J; Feng Y; Yang Z; Shang J
    J Transl Med; 2019 Oct; 17(1):347. PubMed ID: 31640738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.
    Guo X; Xiong L; Sun T; Peng R; Zou L; Zhu H; Zhang J; Li H; Zhao J
    Diagn Pathol; 2012 Apr; 7():44. PubMed ID: 22515642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.
    Li H; Huang W; Luo R
    Diagn Pathol; 2015 Jul; 10():117. PubMed ID: 26194496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
    Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
    Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and validation of a three-microRNA signature as prognostic biomarker in patients with hepatocellular carcinoma.
    Zhang X; Ma L; Zhai L; Chen D; Li Y; Shang Z; Zhang Z; Gao Y; Yang W; Li Y; Pan Y
    Int J Med Sci; 2021; 18(4):984-999. PubMed ID: 33456356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of microRNA-372 associates with tumor progression and prognosis in hepatocellular carcinoma.
    Gu H; Guo X; Zou L; Zhu H; Zhang J
    Mol Cell Biochem; 2013 Mar; 375(1-2):23-30. PubMed ID: 23291979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
    Chen L; Jiang M; Yuan W; Tang H
    J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma.
    Tian YW; Shen Q; Jiang QF; Wang YX; Li K; Xue HZ
    Minerva Med; 2017 Apr; 108(2):108-113. PubMed ID: 27879964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
    Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
    Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-level expression of microRNA-375 predicts poor prognosis in hepatocellular carcinoma.
    Zhou N; Wu J; Wang X; Sun Z; Han Q; Zhao L
    Tumour Biol; 2016 Feb; 37(2):2145-52. PubMed ID: 26349912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.